Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Lessons from the COVID-19 pandemic and recent developments on the communication of clinical trials, publishing practices, and research integrity: in conversation with Dr. David Moher
10
Zitationen
8
Autoren
2022
Jahr
Abstract
Dr. Moher advocates for policy to further improve the reporting of trials and health research. The COVID-19 pandemic has exposed how a lack of open science practices and flawed systems incentivizing researchers to publish can harm research integrity. There is a need for a culture shift in assessing careers and "productivity" in academia, and this requires collaborative top-down and bottom-up approaches.
Ähnliche Arbeiten
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · 86.626 Zit.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 · 82.870 Zit.
The Measurement of Observer Agreement for Categorical Data
1977 · 77.189 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 62.998 Zit.
Measuring inconsistency in meta-analyses
2003 · 61.690 Zit.